Creative Medical Technology Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Creative Medical Technology Holdings, Inc., a Nevada corporation and emerging growth company, on April 20, 2018. The report covers events occurring between April 12, 2018, and April 19, 2018.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a capital structure event involving the issuance of equity securities.
Material Changes
Under Item 3.02 (Unregistered Sales of Equity Securities), the company reported the following issuances pursuant to Section 3(a)(9) of the Securities Act of 1933:
- 114,017,952 shares issued upon the conversion of outstanding notes.
- 15,009,325 shares issued upon the cashless exercise of outstanding warrants.
- Total Issuance: 129,027,277 shares.
- Resulting Capitalization: As of April 19, 2018, the company had 609,062,989 shares of common stock outstanding.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies beyond the disclosure of the unregistered equity sales.
Investor Verification Checklist
- Verify the total number of outstanding shares (609,062,989) as of April 19, 2018.
- Confirm the terms of the notes converted and warrants exercised to understand the dilution impact.
- Review the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.